How Insulin Pumps and Closed-Loop Systems Are Changing Type 1 Diabetes Care
From children to older adults to pregnant women, automated insulin delivery technology is helping people with Type 1 diabetes spend more time in their target glucose range. Here's what the latest research shows.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Insulin pumps deliver precise amounts of insulin automatically, reducing manual injections and helping achieve better glucose control
- Closed-loop systems (also called automated insulin delivery) keep blood sugar more stable by adjusting insulin continuously based on real-time glucose readings
- Research shows closed-loop systems help people spend significantly more time in their target glucose range compared to standard pump or injection therapy
- These technologies are being studied and used across different age groups—from very young children to older adults—with positive results for safety and glucose control
- While technology improves diabetes management, individual treatment plans should be tailored to each person's goals and needs
What Are Insulin Pumps and Closed-Loop Systems?
An insulin pump is a small device that delivers insulin continuously throughout the day and night, replacing the need for multiple daily injections. Think of it as a 24-hour-on-call helper that provides insulin precisely when your body needs it.
A closed-loop system takes automation a step further. It combines an insulin pump with a continuous glucose monitor (CGM) that reads your blood sugar in real time. The system automatically adjusts insulin delivery based on your glucose levels—without requiring you to calculate doses manually. Some advanced systems even use two hormones, insulin and glucagon, to manage glucose more naturally.
What Does the Research Show?
A large review of 65 clinical trials involving 3,623 people with Type 1 diabetes found that automated insulin delivery systems significantly improved glucose control. People using these systems spent on average 11.74% more time in their target glucose range compared to those using standard insulin pumps or injections.
The benefits appear across different life stages. In a study of pregnant women with Type 1 diabetes, those using closed-loop systems spent 65.4% of the time in their pregnancy-specific target glucose range (63-140 mg/dL), compared to 50.3% for those using standard care—a meaningful difference that matters for both mother and baby.
For older adults aged 65 and older, closed-loop systems reduced dangerous low blood sugar episodes. When using a hybrid closed-loop system, the time spent with glucose below 70 mg/dL dropped from 2.57% to 1.58%, compared to standard sensor-augmented pump therapy.
Early research in very young children (ages 1-7) is also underway, examining whether 24/7 automated glucose control improves time in range in this vulnerable age group.
Quality of Life and Glucose Stability
Beyond the numbers, diabetes technology is designed to ease the daily burden of managing Type 1 diabetes. Research shows these tools promote self-efficacy—the confidence that you can manage your condition—and enhance overall quality of life for both people with Type 1 diabetes and their families.
For parents of children with Type 1 diabetes, automated systems can reduce the stress of constant glucose monitoring and manual insulin calculations. For individuals themselves, more stable glucose levels mean fewer extreme highs and lows, which translates to better energy, mood, and ability to participate in daily activities.
Is This Technology Right for You?
While the evidence for automated insulin delivery is strong, the best approach to diabetes management is individual. Factors like your age, how long you've had Type 1 diabetes, your baseline glucose control, lifestyle, and personal preferences all matter when choosing a treatment plan.
If you're interested in learning whether an insulin pump or closed-loop system might be right for you, talk with your diabetes care team. They can discuss the options available to you, how these systems work, and whether they align with your diabetes management goals.
Evidence label
Origin: YouTube / Narayana Health (Video report). Evidence: Video report, corroborated with 6 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Our own writing on the same ground.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryLiving With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Research summaryLiving With T1DContinuous Glucose Monitoring and Mortality: What New Research ShowsNews report, corroborated with 4 indexed studies
- Research summaryLiving With T1DHow Automated Insulin Delivery Systems Work and What the Research ShowsVideo report, corroborated with 5 indexed studies
- Research summaryLiving With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Research summaryLiving With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Research summaryLiving With T1DNew Trials Test Fully Closed Loop Insulin Systems That Could Eliminate Carb CountingVideo report, corroborated with 2 indexed studies